📍 Location: Gaithersburg, Maryland
Client: MedImmune (AstraZeneca Company)
Scope of Work: Selective Interior Demolition
Industry: Pharmaceutical / Healthcare Facility
Project Overview:
APRO Remodeling & Construction was contracted to perform precise and controlled selective demolition services at the MedImmune research and production facility, a premier biotech company founded in 1987 and known for its advanced pharmaceutical developments including Synagis and FluMist.
This project required careful removal of non-structural interior components in a highly regulated, operational facility. Our scope included:
-
Interior wall and partition removal
-
Flooring and ceiling dismantling
-
MEP (mechanical, electrical, plumbing) disconnections in coordination with on-site engineers
-
Dust control and debris hauling per industry and facility protocols
Project Highlights:
-
Work performed in sensitive lab and R&D environments with minimal disruption to ongoing operations
-
Strict adherence to OSHA safety standards and pharmaceutical site compliance protocols
-
Collaboration with facility managers and engineers to meet tight scheduling and cleanliness requirements
Outcome:
The project was completed on time and with zero incidents, enabling MedImmune to continue facility upgrades essential for their ongoing research in oncology, immunology, and pediatric infection treatment.